Abstract
Among the 23 different fibril proteins described in human amyloidosis, transthyretin is associated with the most common hereditary form of the disease and its knowledge is corroborated through about 150 crystal structures in addition to thousands of small ligands tested as fibril formation inhibitors. In spite of the large amount of available data, the mechanism of transthyretin aggregation and its inhibition through binding with small ligands is not clear. In the last decade, many groups of researchers have attempted to apply computational procedures to simulate these phenomena, with the aim of understanding them in depth and in order to rationalize the design of new promising inhibitors. A summary of the main molecular dynamics, docking, and structure-activity relationship studies carried out on transthyretin are reviewed here, and the most successful results and new trends are described in detail.
Keywords: Amyloid fibril, docking, SAR, computational chemistry, molecular dynamics, pharmacophoric model, transthyretin, virtual screening, screening, human amyloidosis
Current Medicinal Chemistry
Title:Computational Studies on Transthyretin
Volume: 19 Issue: 15
Author(s): G. Ortore, A. Martinelli
Affiliation:
Keywords: Amyloid fibril, docking, SAR, computational chemistry, molecular dynamics, pharmacophoric model, transthyretin, virtual screening, screening, human amyloidosis
Abstract: Among the 23 different fibril proteins described in human amyloidosis, transthyretin is associated with the most common hereditary form of the disease and its knowledge is corroborated through about 150 crystal structures in addition to thousands of small ligands tested as fibril formation inhibitors. In spite of the large amount of available data, the mechanism of transthyretin aggregation and its inhibition through binding with small ligands is not clear. In the last decade, many groups of researchers have attempted to apply computational procedures to simulate these phenomena, with the aim of understanding them in depth and in order to rationalize the design of new promising inhibitors. A summary of the main molecular dynamics, docking, and structure-activity relationship studies carried out on transthyretin are reviewed here, and the most successful results and new trends are described in detail.
Export Options
About this article
Cite this article as:
G. Ortore, A. Martinelli , Computational Studies on Transthyretin, Current Medicinal Chemistry 2012; 19 (15) . https://dx.doi.org/10.2174/092986712800269344
DOI https://dx.doi.org/10.2174/092986712800269344 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by
Inhibiting NLRP3 Inflammasome and Lung Permeability
Current Pharmaceutical Design Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
Current Pharmaceutical Design Progress in the Discovery of Polo-like Kinase Inhibitors
Current Topics in Medicinal Chemistry Biological Activities and Corresponding SARs of Andrographolide and Its Derivatives
Mini-Reviews in Medicinal Chemistry In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Current Pharmaceutical Design The Roles of Sox Family Genes in Sarcoma
Current Drug Targets From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota
Combinatorial Chemistry & High Throughput Screening Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Infectious Agents and Neurodegenerative Diseases: Exploring the Links
Current Topics in Medicinal Chemistry Adeno-Associated Virus Vectors: Immunobiology and Potential Use for Immune Modulation
Current Gene Therapy An Agathokakological Tale of Δ<sup>9</sup>-THC: Exploration of Possible Biological Targets
Current Drug Targets Diagnosis of Pathogens Using DNA Microarray
Recent Patents on Biotechnology Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality
Current Neurovascular Research The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review
Current Cancer Drug Targets Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Antimicrobial Resistance: The Potent Enemy Lurking Behind COVID-19
Coronaviruses Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?
Current Medicinal Chemistry Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued)